Shereen McIntyre

Shereen McIntyre is Executive Director, Data Management at Alumis and brings more than 22 years of pharmaceutical and biotechnology industry experience. Prior to joining Alumis, Shereen was Executive Director of Data Management at Bristol Myers Squibb, where she led integration and transition activities for her function following the company’s acquisition of MyoKardia. At MyoKardia, Shereen built and lead the data management function, inclusive of clinical programming, ensuring successful completion of key data deliverables in support of the company’s New Drug Application filing. Before MyoKardia, Shereen also served as head of data management at Avanir Pharmaceuticals and Five Prime Therapeutics, respectively. Shereen started her career at Amylin Pharmaceuticals in San Diego, where she held biometrics positions of increasing responsibility over her 15-year tenure at the company. Throughout her career, she has supported multiple regulatory drug filings and has helped bring multiple drugs to approval. Shereen holds a MBA in Management from San Diego State University and a Bachelor of Science in Biochemistry and Cell Biology from UC San Diego.